Early and Stage-Dependent Cardiopulmonary Fitness Impairment in Pediatric CKD

Oscar Werner1,2,3, Marc Fila1,4, Fanchon Herman5

  • 1Department of Specialized Pediatrics, Unit of Pediatric Cardiology and Nephrology, Montpellier University Hospital, France.

Insights

Children with chronic kidney disease (CKD) have significantly lower cardiopulmonary fitness, with impaired maximal oxygen uptake (VO2max) evident even in early stages. This reduced fitness is linked to clinical factors, suggesting early screening is crucial.

Area of Science:

  • Pediatric Nephrology
  • Cardiovascular Health in Chronic Disease
  • Exercise Physiology

Background:

  • Children with chronic kidney disease (CKD) face elevated cardiovascular risks.
  • Cardiopulmonary fitness, a key prognostic indicator, is underassessed in routine pediatric CKD care.
  • Utilizing Z-scores for maximal oxygen uptake (VO2max) can enhance early risk stratification.

Purpose of the Study:

  • To assess cardiopulmonary fitness in children with CKD using standardized testing.
  • To determine the prevalence of impaired VO2max in this population.
  • To identify factors associated with VO2max in pediatric CKD.

Main Methods:

  • Prospective, multicenter study involving children aged 6-17 with CKD stages 2-5 (KDIGO classification).
  • Standardized cardiopulmonary exercise testing (CPET) was performed, with VO2max expressed as Z-scores.
  • Impaired fitness was defined as a VO2max Z-score below -1.64; multivariable regression analyzed determinants of VO2max.

Main Results:

  • 77 of 88 enrolled children completed CPET, revealing a mean VO2max Z-score of -1.8±2.1, approximately 10 mL/kg/min lower than reference values.
  • 57% of participants exhibited impaired cardiopulmonary fitness.
  • VO2max Z-scores declined progressively with increasing CKD stage and were independently associated with hemoglobin, pulmonary function (FEV1), ventilatory efficiency (VE/VCO2 slope), and ventilatory anaerobic threshold (VAT).

Conclusions:

  • Children with CKD demonstrate substantially reduced cardiopulmonary fitness, with a notable decline evident even in early disease stages.
  • The degree of VO2max impairment is significant and correlates with potentially modifiable clinical and functional factors.
  • Early CPET-based screening and tailored, multidisciplinary rehabilitation programs are recommended for pediatric CKD patients.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...